{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:47:01Z","timestamp":1780501621631,"version":"3.54.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Antimicrobial resistance is associated with increased morbidity in secondary infections and is a global threat owning to the ubiquitous nature of resistance genes in the environment. Recent estimate put the deaths associated with bacterial antimicrobial resistance in 2019 at 4.95 million worldwide. Lymphatic filariasis (LF), a Neglected Tropical Disease (NTD), is associated with the poor living in the tropical regions of the world. LF patients are prone to developing acute dermatolymphangioadenitis (ADLA), a condition that puts them at risk of developing secondary bacterial infections due to skin peeling. ADLA particularly worsens the prognosis of patients leading to usage of antibiotics as a therapeutic intervention. This may result in inappropriate usage of antibiotics due to self-medication and non-compliance; exacerbating antimicrobial resistance in LF patients. In this perspective, we assessed the possibilities of antimicrobial resistance in LF patients. We focused on antibiotic usage, antibiotic resistance in <jats:italic>Staphylococcus aureus<\/jats:italic>, <jats:italic>Escherichia coli<\/jats:italic> and <jats:italic>Pseudomonas aeruginosa<\/jats:italic> isolates and looked at genes (<jats:italic>mec<\/jats:italic>A and Extended-spectrum beta-lactamase [<jats:italic>bla<\/jats:italic>CTX-M, <jats:italic>bla<\/jats:italic>SHV and <jats:italic>bla<\/jats:italic>TEM]) coding for resistance in multi-drug resistant (MDR) bacterial isolates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the sixty (60) participants, fifty-four (<jats:italic>n<\/jats:italic>\u2009=\u200954, 90%) were within 31\u201360\u00a0years of age, twenty (<jats:italic>n<\/jats:italic>\u2009=\u200920, 33.33%) were unemployed and thirty-eight (<jats:italic>n<\/jats:italic>\u2009=\u200938, 50.67%) had wounds aged seven (7) months and above. Amoxicillin (54%) and chloramphenicol (22%) were the most frequently used antibiotics for self-medication. <jats:italic>Staphylococcus aureus<\/jats:italic> isolates (<jats:italic>n<\/jats:italic>\u2009=\u200926) were mostly resistant to penicillin (<jats:italic>n<\/jats:italic>\u2009=\u200923, 88.46%) and least resistant to erythromycin (<jats:italic>n<\/jats:italic>\u2009=\u20092, 7.69%). <jats:italic>Escherichia coli<\/jats:italic> isolates (<jats:italic>n<\/jats:italic>\u2009=\u20095) were resistant to tetracycline (<jats:italic>n<\/jats:italic>\u2009=\u20095, 100%) and ampicillin (<jats:italic>n<\/jats:italic>\u2009=\u20095, 100%) but were sensitive to meropenem (<jats:italic>n<\/jats:italic>\u2009=\u20095, 100%). <jats:italic>Pseudomonas aeruginosa<\/jats:italic> isolates (<jats:italic>n<\/jats:italic>\u2009=\u20098) were most resistant to meropenem (<jats:italic>n<\/jats:italic>\u2009=\u20093, 37.50%) and to a lesser extent ciprofloxacin (<jats:italic>n<\/jats:italic>\u2009=\u20092, 25%), gentamicin (<jats:italic>n<\/jats:italic>\u2009=\u20092, 25%) and ceftazidime (<jats:italic>n<\/jats:italic>\u2009=\u20092, 25%). Multi-drug resistant methicillin resistant <jats:italic>Staphylococcus aureus<\/jats:italic> (MRSA), cephalosporin resistant <jats:italic>Escherichia coli<\/jats:italic>\u00a0and carbapenem resistant <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\u00a0were four (<jats:italic>n<\/jats:italic>\u2009=\u20094, 15.38%), two (<jats:italic>n<\/jats:italic>\u2009=\u20092, 40%) and two (<jats:italic>n<\/jats:italic>\u2009=\u20092, 25%) respectively. ESBL (<jats:italic>bla<\/jats:italic>CTX-M) and <jats:italic>mec<\/jats:italic>A genes were implicated in the resistance mechanism of <jats:italic>Escherichia coli<\/jats:italic>\u00a0and MRSA, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The findings show presence of MDR isolates from LF patients presenting with chronic wounds; thus, the need to prioritize resistance of MDR bacteria into treatment strategies optimizing morbidity management protocols. This could guide antibiotic selection for treating LF patients presenting with ADLA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12866-022-02624-9","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T11:03:38Z","timestamp":1665486218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Multi-drug resistant bacteria isolates from lymphatic filariasis patients in the Ahanta West District, Ghana"],"prefix":"10.1186","volume":"22","author":[{"given":"Bill Clinton","family":"Aglomasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia Kyerewaa","family":"Adu-Asiamah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Opoku","family":"Asiedu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Kini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Kobla Atsu","family":"Amewu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy Gyau","family":"Boahen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Wireko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac Kingsley","family":"Amponsah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaw Duah","family":"Boakye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian Etsiapa","family":"Boamah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kwarteng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,11]]},"reference":[{"issue":"6","key":"2624_CR1","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00281-012-0346-4","volume":"34","author":"S Babu","year":"2012","unstructured":"Babu S, Nutman TB. Immunopathogenesis of lymphatic filarial disease. Semin Immunopathol. 2012;34(6):847\u201361.","journal-title":"Semin Immunopathol"},{"key":"2624_CR2","unstructured":"World Health Organization. Lymphatic filariasis [Internet]. 2021. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/lymphatic-filariasis. cited 2022 Feb 11"},{"key":"2624_CR3","unstructured":"World Health Organization. Global Programme to Eliminate Lymphatic Filariasis Practical Entomology. Vol. 91, Weekly epidemiological record. 2019. p. 1\u2013107. Available from: https:\/\/www.who.int\/publications\/i\/item\/who-wer9441-457-472. cited 2022 Jul 5"},{"issue":"1","key":"2624_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40249-019-0578-9","volume":"8","author":"Y Fang","year":"2019","unstructured":"Fang Y, Zhang Y. Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China. Infect Dis Poverty. 2019;8(1):1\u201310.","journal-title":"Infect Dis Poverty"},{"issue":"7","key":"2624_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S2214-109X(18)30124-4","volume":"6","author":"H Negussie","year":"2018","unstructured":"Negussie H, Molla M, Ngari M, Berkley JA, Kivaya E, Njuguna P, et al. Lymphoedema management to prevent acute dermatolymphangioadenitis in podoconiosis in northern Ethiopia (GoLBeT): a pragmatic randomised controlled trial. Lancet Glob Heal. 2018;6(7):1\u20139. https:\/\/doi.org\/10.1016\/S2214-109X(18)30124-4.","journal-title":"Lancet Glob Heal"},{"key":"2624_CR6","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3389\/fmicb.2020.01434","volume":"11","author":"P Manohar","year":"2020","unstructured":"Manohar P, Loh B, Athira S, Nachimuthu R, Hua X, Welburn SC, et al. Secondary Bacterial Infections During Pulmonary Viral Disease: Phage Therapeutics as Alternatives to Antibiotics? Front Microbiol. 2020;11:1434.","journal-title":"Front Microbiol"},{"key":"2624_CR7","unstructured":"World Health Organization. Antimicrobial resistance. 2021. Available from: https:\/\/www.who.int\/health-topics\/antimicrobial-resistance. cited 2022 Feb 11"},{"key":"2624_CR8","unstructured":"World Health Organization. Antibiotic resistance. 2020. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antibiotic-resistance"},{"issue":"2","key":"2624_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4103\/2229-5070.138544","volume":"4","author":"P Mahalingashetti","year":"2014","unstructured":"Mahalingashetti P, Subramanian R, Vijay A, Jayker S. Lymphatic filariasis: A view at pathological diversity. Trop Parasitol. 2014;4(2):128.","journal-title":"Trop Parasitol"},{"issue":"8","key":"2624_CR10","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1021\/acsinfecdis.8b00111","volume":"4","author":"A Bogoslowski","year":"2018","unstructured":"Bogoslowski A, Kubes P. Lymph Nodes: The Unrecognized Barrier against Pathogens. ACS Infect Dis. 2018;4(8):1158\u201361.","journal-title":"ACS Infect Dis"},{"issue":"April","key":"2624_CR11","first-page":"1","volume":"11","author":"GR Kathamuthu","year":"2020","unstructured":"Kathamuthu GR, Munisankar S, Banurekha VV, Nair D, Sridhar R, Babu S. Filarial Coinfection Is Associated With Higher Bacterial Burdens and Altered Plasma Cytokine and Chemokine Responses in Tuberculous Lymphadenitis. Front Immunol. 2020;11(April):1\u20139.","journal-title":"Front Immunol"},{"issue":"12","key":"2624_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0189621","volume":"12","author":"RC Founou","year":"2017","unstructured":"Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis. PLoS ONE. 2017;12(12):1\u201318.","journal-title":"PLoS ONE"},{"issue":"10325","key":"2624_CR13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355.","journal-title":"Lancet"},{"issue":"3","key":"2624_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.epidem.2009.09.001","volume":"1","author":"A Handel","year":"2009","unstructured":"Handel A, Longini IM, Antia R. Intervention strategies for an influenza pandemic taking into account secondary bacterial infections. Epidemics. 2009;1(3):185\u201395.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1016\/j.epidem.2009.09.001.","journal-title":"Epidemics"},{"issue":"FEB","key":"2624_CR15","first-page":"1","volume":"5","author":"D Destoumieux-Garz\u00f3n","year":"2018","unstructured":"Destoumieux-Garz\u00f3n D, Mavingui P, Boetsch G, Boissier J, Darriet F, Duboz P, et al. The one health concept: 10 years old and a long road ahead. Front Vet Sci. 2018;5(FEB):1\u201313.","journal-title":"Front Vet Sci"},{"issue":"7159","key":"2624_CR16","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/bmj.317.7159.654","volume":"317","author":"H Goossens","year":"1998","unstructured":"Goossens H, Sprenger MJW. Community acquired infections and bacterial resistance. Br Med J. 1998;317(7159):654\u20137.","journal-title":"Br Med J"},{"issue":"1","key":"2624_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-34918-2","volume":"8","author":"M Cervera-Alamar","year":"2018","unstructured":"Cervera-Alamar M, Guzm\u00e1n-Markevitch K, \u017diemyt\u0117 M, Ort\u00ed L, Bernab\u00e9-Quispe P, Pineda-Lucena A, et al. Mobilisation Mechanism of Pathogenicity Islands by Endogenous Phages in Staphylococcus aureus clinical strains. Sci Rep. 2018;8(1):1\u201313.","journal-title":"Sci Rep"},{"issue":"December","key":"2624_CR18","first-page":"1","volume":"10","author":"VS Braz","year":"2020","unstructured":"Braz VS, Melchior K, Moreira CG. Escherichia coli as a Multifaceted Pathogenic and Versatile Bacterium. Front Cell Infect Microbiol. 2020;10(December):1\u20139.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"2624_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/antibiotics10040415","volume":"10","author":"L Kakoullis","year":"2021","unstructured":"Kakoullis L, Papachristodoulou E, Chra P, Panos G. Mechanisms of antibiotic resistance in important gram-positive and gram-negative pathogens and novel antibiotic solutions. Antibiotics. 2021;10(4):415.","journal-title":"Antibiotics"},{"issue":"2","key":"2624_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrmicro818","volume":"2","author":"JB Kaper","year":"2004","unstructured":"Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2(2):123\u201340.","journal-title":"Nat Rev Microbiol"},{"key":"2624_CR21","doi-asserted-by":"publisher","first-page":"2796412","DOI":"10.1155\/2016\/2796412","volume":"2016","author":"S Bekal","year":"2016","unstructured":"Bekal S, Vincent A, Lin A, Harel J, C\u00f4t\u00e9 JC, Tremblay C. A Fatal Case of Necrotizing Fasciitis Caused by a Highly Virulent Escherichia coli Strain. Can J Infect Dis Med Microbiol. 2016;2016:2796412.","journal-title":"Can J Infect Dis Med Microbiol."},{"issue":"6","key":"2624_CR22","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.ajpath.2014.11.030","volume":"185","author":"SD Kobayashi","year":"2015","unstructured":"Kobayashi SD, Malachowa N, Deleo FR. Pathogenesis of Staphylococcus aureus abscesses. Am J Pathol. 2015;185(6):1518\u201327.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1016\/j.ajpath.2014.11.030.","journal-title":"Am J Pathol"},{"issue":"3","key":"2624_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2165\/11539770-000000000-00000","volume":"12","author":"DC Wu","year":"2011","unstructured":"Wu DC, Chan WW, Metelitsa AI, Fiorillo L, Lin AN. Pseudomonas skin infection: Clinical features, epidemiology, and management. Am J Clin Dermatol. 2011;12(3):157\u201369.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"2624_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3390\/antibiotics2020237","volume":"2","author":"F Corona","year":"2013","unstructured":"Corona F, Martinez JL. Phenotypic resistance to antibiotics. Antibiotics. 2013;2(2):237\u201355.","journal-title":"Antibiotics"},{"issue":"9","key":"2624_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro2200","volume":"7","author":"HF Chambers","year":"2009","unstructured":"Chambers HF, DeLeo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol. 2009;7(9):629\u201341.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1038\/nrmicro2200.","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"2624_CR26","doi-asserted-by":"publisher","first-page":"FSO464","DOI":"10.2144\/fsoa-2019-0122","volume":"6","author":"RR Gurung","year":"2020","unstructured":"Gurung RR, Maharjan P, Chhetri GG. Antibiotic resistance pattern of Staphylococcus aureus with reference to MRSA isolates from pediatric patients. Futur Sci OA. 2020;6(4):FSO464.","journal-title":"Futur Sci OA"},{"issue":"36","key":"2624_CR27","doi-asserted-by":"publisher","first-page":"17906","DOI":"10.1073\/pnas.1906958116","volume":"116","author":"N Fraz\u00e3o","year":"2019","unstructured":"Fraz\u00e3o N, Sousa A, L\u00e4ssig M, Gordo I. Horizontal gene transfer overrides mutation in Escherichia coli colonizing the mammalian gut. Proc Natl Acad Sci U S A. 2019;116(36):17906\u201315.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"2624_CR28","doi-asserted-by":"publisher","first-page":"10956","DOI":"10.1093\/nar\/gkab827","volume":"49","author":"G Dangla-P\u00e9lissier","year":"2021","unstructured":"Dangla-P\u00e9lissier G, Roux N, Schmidt V, Chambonnier G, Ba M, Sebban-Kreuzer C, et al. The horizontal transfer of P. aeruginosa PA14 ICE PAPI-1 is controlled by a transcriptional triad between TprA, NdpA2 and MvaT. Nucleic Acids Res. 2021;49(19):10956\u201374.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2624_CR29","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/s41467-022-29283-8","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Zhang Q, Wang T, Xu N, Lu T, Hong W, et al. Assessment of global health risk of antibiotic resistance genes. Nat Commun. 2022;13(1):1553.","journal-title":"Nat Commun"},{"issue":"27323","key":"2624_CR30","first-page":"1","volume":"9","author":"M Miragaia","year":"2018","unstructured":"Miragaia M. Factors contributing to the evolution of Meca-mediated \u03b2-lactam resistance in staphylococci: Update and new insights from whole genome sequencing (WGS). Front Microbiol. 2018;9(27323):1\u201316.","journal-title":"Front Microbiol"},{"issue":"3","key":"2624_CR31","doi-asserted-by":"publisher","first-page":"dlab092","DOI":"10.1093\/jacamr\/dlab092","volume":"3","author":"M Castanheira","year":"2021","unstructured":"Castanheira M, Simner PJ, Bradford PA. Extended-spectrum \u03b2 -lactamases: an update on their characteristics, epidemiology and detection. JAC-Antimicrobial Resist. 2021;3(3):dlab092.","journal-title":"JAC-Antimicrobial Resist"},{"issue":"1","key":"2624_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-39730-0","volume":"9","author":"AA Ramadan","year":"2019","unstructured":"Ramadan AA, Abdelaziz NA, Amin MA, Aziz RK. Novel blaCTX-M variants and genotype-phenotype correlations among clinical isolates of extended spectrum beta lactamase-producing Escherichia coli. Sci Rep. 2019;9(1):1\u201312.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1038\/s41598-019-39730-0.","journal-title":"Sci Rep"},{"issue":"1374","key":"2624_CR33","first-page":"1","volume":"7","author":"A Liakopoulos","year":"2016","unstructured":"Liakopoulos A, Mevius D, Ceccarelli D. A review of SHV extended-spectrum \u03b2-lactamases: Neglected yet ubiquitous. Front Microbiol. 2016;7(1374):1\u201327.","journal-title":"Front Microbiol"},{"issue":"1","key":"2624_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-016-0144-2","volume":"15","author":"D Oduro-Mensah","year":"2016","unstructured":"Oduro-Mensah D, Obeng-Nkrumah N, Bonney EY, Oduro-Mensah E, Twum-Danso K, Osei YD, et al. Genetic characterization of TEM-type ESBL-associated antibacterial resistance in Enterobacteriaceae in a tertiary hospital in Ghana. Ann Clin Microbiol Antimicrob. 2016;15(1):1\u20139.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"2624_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3184\/003685002783238870","volume":"85","author":"PD Stapleton","year":"2002","unstructured":"Stapleton PD, Taylor PW. Methicillin resistance in Staphylococcus aureus\u202f: mechanisms and modulation. Sci Prog. 2002;85(1):57\u201372.","journal-title":"Sci Prog"},{"issue":"1","key":"2624_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40560-020-0429-6","volume":"8","author":"T Sawa","year":"2020","unstructured":"Sawa T, Kooguchi K, Moriyama K. Molecular diversity of extended-spectrum \u03b2-lactamases and carbapenemases, and antimicrobial resistance. J Intensive Care. 2020;8(1):1\u201313.","journal-title":"J Intensive Care"},{"issue":"1","key":"2624_CR37","first-page":"46","volume":"11","author":"T Ryan","year":"2016","unstructured":"Ryan T. Matts hypothesis: How simple strategies can lead to better outcomes. J Lymphoedema. 2016;11(1):46\u20138.","journal-title":"J Lymphoedema"},{"key":"2624_CR38","doi-asserted-by":"publisher","unstructured":"Goel TC, Goel A. Filarial Cellulitis\u2013Abscess. In: Lymphatic Filariasis. Springer, Singapore; 2016. p. 141\u20133. Available from: https:\/\/doi.org\/10.1007\/978-981-10-2257-9_18. cited 2022 Jul 5","DOI":"10.1007\/978-981-10-2257-9_18"},{"issue":"1","key":"2624_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-021-10170-8","volume":"21","author":"SO Asiedu","year":"2021","unstructured":"Asiedu SO, Kwarteng A, Amewu EKA, Kini P, Aglomasa BC, Forkuor JB. Financial burden impact quality of life among lymphatic Filariasis patients. BMC Public Health. 2021;21(1):1\u201310.","journal-title":"BMC Public Health"},{"issue":"6","key":"2624_CR40","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/2042098614554919","volume":"5","author":"C Llor","year":"2014","unstructured":"Llor C, Bjerrum L. Antimicrobial resistance: Risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229\u201341.","journal-title":"Ther Adv Drug Saf"},{"issue":"4","key":"2624_CR41","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.sjbs.2017.01.004","volume":"24","author":"IA Rather","year":"2017","unstructured":"Rather IA, Kim BC, Bajpai VK, Park YH. Self-medication and antibiotic resistance: Crisis, current challenges, and prevention. Saudi J Biol Sci. 2017;24(4):808\u201312.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1016\/j.sjbs.2017.01.004.","journal-title":"Saudi J Biol Sci"},{"issue":"3","key":"2624_CR42","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5001\/omj.2019.37","volume":"34","author":"GV Asokan","year":"2019","unstructured":"Asokan GV, Ramadhan T, Ahmed E, Sanad H. WHO global priority pathogens list: A bibliometric analysis of medline-pubmed for knowledge mobilization to infection prevention and control practices in Bahrain. Oman Med J. 2019;34(3):184\u201393.","journal-title":"Oman Med J"},{"issue":"1","key":"2624_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-017-4910-7","volume":"17","author":"SK Yevutsey","year":"2017","unstructured":"Yevutsey SK, Buabeng KO, Aikins M, Anto BP, Biritwum RB, Frimodt-M\u00f8ller N, et al. Situational analysis of antibiotic use and resistance in Ghana: Policy and regulation. BMC Public Health. 2017;17(1):1\u20137.","journal-title":"BMC Public Health"},{"issue":"807955","key":"2624_CR44","first-page":"1","volume":"13","author":"J Turner","year":"2022","unstructured":"Turner J, Muraoka A, Bedenbaugh M, Childress B, Pernot L, Wiencek M, et al. The Chemical Relationship Among Beta-Lactam Antibiotics and Potential Impacts on Reactivity and Decomposition. Front Microbiol. 2022;13(807955):1\u201318.","journal-title":"Front Microbiol"},{"issue":"1","key":"2624_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-07142-2","volume":"12","author":"SY Tan","year":"2022","unstructured":"Tan SY, Khan RA, Khalid KE, Chong CW, Bakhtiar A. Correlation between antibiotic consumption and the occurrence of multidrug-resistant organisms in a Malaysian tertiary hospital: a 3-year observational study. Sci Rep. 2022;12(1):1\u20139.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1038\/s41598-022-07142-2.","journal-title":"Sci Rep"},{"issue":"7","key":"2624_CR46","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10096-007-0321-5","volume":"26","author":"S Riedel","year":"2007","unstructured":"Riedel S, Beekmann SE, Heilmann KP, Richter SS, Garcia-De-Lomas J, Ferech M, et al. Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis. 2007;26(7):485\u201390.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2624_CR47","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0140-6736(05)17907-0","volume":"365","author":"H Goossens","year":"2005","unstructured":"Goossens H, Ferech M, Stichele RV, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579\u201387.","journal-title":"Lancet"},{"issue":"2489063","key":"2624_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/2489063","volume":"2019","author":"OA Muhie","year":"2019","unstructured":"Muhie OA. Antibiotic Use and Resistance Pattern in Ethiopia: Systematic Review and Meta-Analysis. Int J Microbiol. 2019;2019(2489063):1\u20139.","journal-title":"Int J Microbiol"},{"key":"2624_CR49","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.2147\/IDR.S262493","volume":"13","author":"UL Urmi","year":"2020","unstructured":"Urmi UL, Sultana F, Hossain B, Alam MS, Mosaddek S, et al. Genotypic to Phenotypic Resistance Discrepancies Identified Involving \u03b2 -Lactamase Genes, blaKPC, blaIMP, blaNDM-1, and blaVIM in Uropathogenic Klebsiella pneumoniae. Infect Drug Resist. 2020;13:2863\u201375.","journal-title":"Infect Drug Resist"},{"issue":"786378","key":"2624_CR50","first-page":"1","volume":"2","author":"S Wireko","year":"2021","unstructured":"Wireko S, Asiedu SO, Kini P, Aglomasa BC, Amewu EKA, Asiedu E, et al. Prevalence of Methicillin-Resistant Staphylococcus Species Among Filarial Lymphedema Patients in Ahanta West District of Ghana. Front Trop Dis. 2021;2(786378):1\u20138.","journal-title":"Front Trop Dis"},{"issue":"12","key":"2624_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/microorganisms8122052","volume":"8","author":"M Wolters","year":"2020","unstructured":"Wolters M, Frickmann H, Christner M, Both A, Rohde H, Oppong K, et al. Molecular characterization of staphylococcus aureus isolated from chronic infected wounds in rural Ghana. Microorganisms. 2020;8(12):1\u20137.","journal-title":"Microorganisms"},{"issue":"2","key":"2624_CR52","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.4314\/ahs.v19i2.26","volume":"19","author":"T Ariom","year":"2019","unstructured":"Ariom T, Iroha I, Moses I, Iroha C, Ude U, Kalu A. Detection and phenotypic characterization of methicillin-resistant Staphylococcus aureus from clinical and community samples in Abakaliki, Ebonyi State. Nigeria Afr Heal Sci. 2019;19(2):2026\u201335.","journal-title":"Nigeria Afr Heal Sci"},{"key":"2624_CR53","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.3389\/fmicb.2019.02763","volume":"10","author":"S Aggarwal","year":"2019","unstructured":"Aggarwal S, Jena S, Panda S, Sharma S, Dhawan B, Nath G, et al. Antibiotic Susceptibility, Virulence Pattern, and Typing of Staphylococcus aureus Strains Isolated From Variety of Infections in India. Front Microbiol. 2019;10:2763.","journal-title":"Front Microbiol"},{"key":"2624_CR54","doi-asserted-by":"publisher","unstructured":"Schaumburg F, Vas Nunes J, M\u00f6nnink G, Falama A Mac, Bangura J, Math\u00e9ron H, et al. Chronic wounds in Sierra Leone: pathogen spectrum and antimicrobial susceptibility. Infection. 2022;(0123456789). Available from: https:\/\/doi.org\/10.1007\/s15010-022-01762-6","DOI":"10.1007\/s15010-022-01762-6"},{"issue":"11","key":"2624_CR55","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1128\/JCM.40.11.3970-3975.2002","volume":"40","author":"CLC Wielders","year":"2002","unstructured":"Wielders CLC, Fluit AC, Brisse S, Verhoef J, Schmitz FJ. mecA gene is widely disseminated in Staphylococcus aureus population. J Clin Microbiol. 2002;40(11):3970\u20135.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2624_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-05631-1","volume":"20","author":"AAA Bediako-Bowan","year":"2020","unstructured":"Bediako-Bowan AAA, Kurtzhals JAL, M\u00f8lbak K, Labi AK, Owusu E, Newman MJ. High rates of multi-drug resistant gram-negative organisms associated with surgical site infections in a teaching hospital in Ghana. BMC Infect Dis. 2020;20(1):1\u20139.","journal-title":"BMC Infect Dis"},{"key":"2624_CR57","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3349\/ymj.1998.39.6.526","volume":"39","author":"T Ito","year":"1998","unstructured":"Ito T, Hiramatsu K. Acquisition of methicillin resistance and progression of multiantibiotic resistance in methicillin-resistant Staphylococcus aureus. Yonsei Med J. 1998;39:526\u201333.","journal-title":"Yonsei Med J"},{"issue":"3","key":"2624_CR58","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/1462-2920.15806","volume":"24","author":"F Sanz-Garc\u00eda","year":"2022","unstructured":"Sanz-Garc\u00eda F, Hernando-Amado S, Mart\u00ednez JL. Evolution under low antibiotic concentrations: a risk for the selection of P. aeruginosa multidrug-resistant mutants in nature. Environ Microbiol. 2022;24(3):1279\u201393.","journal-title":"Environ Microbiol"},{"key":"2624_CR59","doi-asserted-by":"crossref","unstructured":"Poole K. P. aeruginosa: Resistance to the max. Front Microbiol. 2011;2(65):1\u201313.","DOI":"10.3389\/fmicb.2011.00065"},{"key":"2624_CR60","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/jac\/18.5.635","volume":"18","author":"A Paull","year":"1986","unstructured":"Paull A, Morgan JR. Emergence of ceftriaxone-resistaiit strains of P. aeruginosa in cystic fibrosis patients The development of antibiotic resistance among P. aeruginosa and other Gram-negative bacilli during treatment with extended spectrum cephalosporins. J Antimicrob Chemother. 1986;18:635\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"2624_CR61","first-page":"1","volume-title":"Breakpoint tables for interpretation of MICs and zone diameters, Version 11.0","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2021","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters, Version 11.0. 2021. p. 1\u2013114."},{"key":"2624_CR62","first-page":"50","volume":"40","author":"Clinical and Laboratory Standards Institute","year":"2020","unstructured":"Clinical and Laboratory Standards Institute. CLSI M100-ED29: 2021 Performance Standards for Antimicrobial Susceptibility Testing, 30th Edition. Clsi. 2020;40:50\u20131.","journal-title":"Clsi"},{"key":"2624_CR63","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"A Magiorakos","year":"2011","unstructured":"Magiorakos A, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria\u202f: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011;18:268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"2624_CR64","doi-asserted-by":"publisher","first-page":"2418902","DOI":"10.1155\/2016\/2418902","volume":"2016","author":"W Dessie","year":"2016","unstructured":"Dessie W, Mulugeta G, Fentaw S, Mihret A, Hassen M, Abebe E. Pattern of bacterial pathogens and their susceptibility isolated from surgical site infections at selected referral hospitals, Addis Ababa, Ethiopia. Int J Microbiol. 2016;2016:2418902.","journal-title":"Int J Microbiol"},{"issue":"12","key":"2624_CR65","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/trstmh\/traa143","volume":"114","author":"D Nigussie","year":"2020","unstructured":"Nigussie D, Makonnen E, Legesse BA, Fekadu A, Davey G. Antimicrobial susceptibility of bacteria isolated from the infected wounds of patients with lymphoedema in East Wollega, Ethiopia. Trans R Soc Trop Med Hyg. 2020;114(12):962\u201373.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"2624_CR66","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.idc.2016.02.004","volume":"30","author":"D van Duin","year":"2016","unstructured":"van Duin D, Paterson DL. Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned. Infect Dis Clin North Am. 2016;30(2):377\u201390.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1016\/j.idc.2016.02.004.","journal-title":"Infect Dis Clin North Am"},{"issue":"6","key":"2624_CR67","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1089\/mdr.2018.0319","volume":"25","author":"R Vivas","year":"2019","unstructured":"Vivas R, Barbosa AAT, Dolabela SS, Jain S. Multidrug-Resistant Bacteria and Alternative Methods to Control Them: An Overview. Microb Drug Resist. 2019;25(6):890\u2013908.","journal-title":"Microb Drug Resist"},{"issue":"11","key":"2624_CR68","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1046\/j.1198-743x.2001.00330.x","volume":"7","author":"M Gniadkowski","year":"2001","unstructured":"Gniadkowski M. Evolution and epidemiology of extended-spectrum \u03b2-lactamases (ESBLs) and ESBL-producing microorganisms. Clin Microbiol Infect. 2001;7(11):597\u2013608.","journal-title":"Clin Microbiol Infect"},{"issue":"9519718","key":"2624_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9519718","volume":"2018","author":"S Ur Rahman","year":"2018","unstructured":"Ur Rahman S, Ali T, Ali I, Khan NA, Han B, Gao J. The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases. Biomed Res Int. 2018;2018(9519718):1\u201314.","journal-title":"Biomed Res Int"},{"issue":"1","key":"2624_CR70","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/jac\/dki166","volume":"56","author":"JDD Pitout","year":"2005","unstructured":"Pitout JDD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum \u03b2-lactamases (ESBLs) in the community. J Antimicrob Chemother. 2005;56(1):52\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"2624_CR71","first-page":"215","volume":"4","author":"MJ Newman","year":"2011","unstructured":"Newman MJ, Frimpong E, Donkor ES. Resistance to antimicrobial drugs in Ghana. Infect Drug Resist. 2011;4:215\u201320.","journal-title":"Infect Drug Resist"},{"issue":"3","key":"2624_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0005280","volume":"11","author":"NK Biritwum","year":"2017","unstructured":"Biritwum NK, de Souza DK, Marfo B, Odoom S, Alomatu B, Asiedu O, et al. Fifteen years of programme implementation for the elimination of Lymphatic Filariasis in Ghana: Impact of MDA on immunoparasitological indicators. PLoS Negl Trop Dis. 2017;11(3):1\u20138.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"2624_CR73","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/cid\/cis486","volume":"55","author":"S Mand","year":"2012","unstructured":"Mand S, Debrah AY, Klarmann U, Batsa L, Marfo-Debrekyei Y, Kwarteng A, et al. Doxycycline improves filarial lymphedema independent of active filarial infection: A randomized controlled trial. Clin Infect Dis. 2012;55(5):621\u201330.","journal-title":"Clin Infect Dis"},{"key":"2624_CR74","unstructured":"American Type Culture Collection. Staphylococcus aureus subsp. aureus Rosenbach | ATCC. Available from: https:\/\/www.atcc.org\/products\/25923. cited 2022 Jun 24"},{"key":"2624_CR75","unstructured":"American Type Culture Collection. Escherichia coli (Migula) Castellani and Chalmers | ATCC. Available from: https:\/\/www.atcc.org\/products\/25922. cited 2022 Jun 24"},{"key":"2624_CR76","unstructured":"American Type Culture Collection. P. aeruginosa (Schroeter) Migula | ATCC Available from: https:\/\/www.atcc.org\/products\/27853. cited 2022 Jun 24"},{"key":"2624_CR77","doi-asserted-by":"publisher","first-page":"7981648","DOI":"10.1155\/2020\/7981648","volume":"2020","author":"C Arjyal","year":"2020","unstructured":"Arjyal C, Kc J, Neupane S. Prevalence of Methicillin-Resistant Staphylococcus aureus in Shrines. Int J Microbiol. 2020;2020:7981648.","journal-title":"Int J Microbiol"},{"key":"2624_CR78","doi-asserted-by":"crossref","unstructured":"Vitko NP, Richardson AR. Laboratory maintenance of methicillin-resistant Staphylococcus aureus (MRSA). Curr Protoc Microbiol. 2013;28:1\u201321.","DOI":"10.1002\/9780471729259.mc09c02s28"},{"issue":"4","key":"2624_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ht7040036","volume":"7","author":"R V\u00e1zquez-L\u00f3pez","year":"2018","unstructured":"V\u00e1zquez-L\u00f3pez R, Solano-G\u00e1lvez S, Le\u00f3n-Ch\u00e1vez BA, Thompson-Bonilla MR, Guerrero-Gonz\u00e1lez T, G\u00f3mez-Conde E. Characterization of gene families encoding beta-lactamases of Gram-negative rods isolated from ready-to-eat vegetables in Mexico City. High-Throughput. 2018;7(4):1\u201315.","journal-title":"High-Throughput"},{"issue":"3","key":"2624_CR80","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/jam.12070","volume":"114","author":"JW Pridgeon","year":"2013","unstructured":"Pridgeon JW, Klesius PH, Garcia JC. Identification and virulence of Chryseobacterium indologenes isolated from diseased yellow perch (Perca flavescens). J Appl Microbiol. 2013;114(3):636\u201343.","journal-title":"J Appl Microbiol"},{"issue":"9","key":"2624_CR81","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3390\/microorganisms9091835","volume":"9","author":"JL Halleran","year":"2021","unstructured":"Halleran JL, Minch R, Slyvester HJ, Jacob ME, Prange T, Baynes R, et al. Comparison of the intestinal pharmacokinetics of two different florfenicol dosing regimens and its impact on the prevalence and phenotypic resistance of e. Coli and enterococcus over time. Microorganisms. 2021;9(9):1835.","journal-title":"Microorganisms"},{"issue":"1","key":"2624_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40550-018-0065-2","volume":"5","author":"G Abakari","year":"2018","unstructured":"Abakari G, Cobbina SJ, Yeleliere E. Microbial quality of ready-to-eat vegetable salads vended in the central business district of tamale, Ghana. Int J Food Contam. 2018;5(1):1\u20139.","journal-title":"Int J Food Contam."},{"key":"2624_CR83","doi-asserted-by":"crossref","unstructured":"Abdisa T. Microbiology examination. Int J Vet Sci Res. 2018;6:065\u201377.","DOI":"10.17352\/ijvsr.s1.110"},{"issue":"8","key":"2624_CR84","first-page":"1","volume":"9","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2003","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Determination of minimum inhibitory concentrations ( MICs ) of antibacterial agents by broth dilution. Clin Microbiol Infect. 2003;9(8):1\u20137.","journal-title":"Clin Microbiol Infect"},{"key":"2624_CR85","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-1-4939-6817-6_10","volume":"1565","author":"SM Daly","year":"2017","unstructured":"Daly SM, Sturge CR, Greenberg DE. Inhibition of Bacterial Growth by Peptide-Conjugated Morpholino Oligomers. Methods Mol Biol. 2017;1565:115\u201322.","journal-title":"Methods Mol Biol"},{"key":"2624_CR86","doi-asserted-by":"publisher","first-page":"902394","DOI":"10.1155\/2012\/902394","volume":"2012","author":"C Agyare","year":"2012","unstructured":"Agyare C, Koffuor GA, Boamah VE, Adu F, Mensah KB, Adu-Amoah L. Antimicrobial and anti-inflammatory activities of Pterygota macrocarpa and Cola gigantea (Sterculiaceae). Evid Based Complement Altern Med. 2012;2012:902394.","journal-title":"Evid Based Complement Altern Med"},{"issue":"12","key":"2624_CR87","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1128\/JCM.01195-16","volume":"54","author":"M Bonjean","year":"2016","unstructured":"Bonjean M, Hodille E, Dumitrescu O, Dupieux C, Mongo CN, Allam C, et al. Disk diffusion testing for detection of methicillin-resistant staphylococci: Does moxalactam improve upon cefoxitin? J Clin Microbiol. 2016;54(12):2905\u20139.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"2624_CR88","first-page":"1","volume":"14","author":"F Moges","year":"2019","unstructured":"Moges F, Eshetie S, Abebe W, Mekonnen F, Dagnew M, Endale A, et al. High prevalence of extended-spectrum beta-lactamase-producing Gram-negative pathogens from patients attending Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar. Amhara region PLoS One. 2019;14(4):1\u201313.","journal-title":"Amhara region PLoS One"},{"issue":"4","key":"2624_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0154389","volume":"11","author":"J Yamagishi","year":"2016","unstructured":"Yamagishi J, Sato Y, Shinozaki N, Ye B, Tsuboi A, Nagasaki M, et al. Comparison of boiling and robotics automation method in DNA extraction for metagenomic sequencing of human oral microbes. PLoS ONE. 2016;11(4):1\u201315.","journal-title":"PLoS ONE"},{"issue":"3","key":"2624_CR90","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jmii.2011.11.015","volume":"45","author":"SP Lin","year":"2012","unstructured":"Lin SP, Liu MF, Lin CF, Shi ZY. Phenotypic detection and polymerase chain reaction screening of extended-spectrum \u03b2-lactamases produced by P. aeruginosa isolates. J Microbiol Immunol Infect. 2012;45(3):200\u20137.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1016\/j.jmii.2011.11.015.","journal-title":"J Microbiol Immunol Infect"},{"key":"2624_CR91","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1469-0691.2011.03715.x","volume":"18","author":"M Stegger","year":"2011","unstructured":"Stegger M, Andersen PS, Kearns A, Pichon B, Holmes MA, Edwards G, et al. Rapid detection, differentiation and typing of methicillin-resistant Staphylococcus aureus harbouring either mecA or the new mecA. Clin Microbiol Infect. 2011;18:395\u2013400.","journal-title":"Clin Microbiol Infect"}],"updated-by":[{"DOI":"10.1186\/s12866-022-02673-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000}}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-022-02624-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-022-02624-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-022-02624-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T03:09:13Z","timestamp":1667617753000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-022-02624-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,11]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2624"],"URL":"https:\/\/doi.org\/10.1186\/s12866-022-02624-9","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,11]]},"assertion":[{"value":"18 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12866-022-02673-0","URL":"https:\/\/doi.org\/10.1186\/s12866-022-02673-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval of the study was granted by the Committee of Human Research and Publications and Ethics, School of Medicinal Science, KNUST with Protocol Identification Number CHRPE\/AP\/649\/19. Written informed consent was obtained from all participants before enrollment into study after the objectives and procedures of the study were explained in details. The participants identity and records were coded before analysis was done. Each participant was given the right to refuse to take part in the study and to withdraw at any time during the study period. Results were made available to the participants for their proper management. All the methods under this study were performed in accordance with the relevant guidelines and regulations as subject to human participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"245"}}